Intercept Pharmaceuticals Inc. [ICPT] fell -77.14% so far this year. What now?

Intercept Pharmaceuticals Inc. [NASDAQ: ICPT] slipped around -1.95 points on Friday, while shares priced at $28.33 at the close of the session, down -6.44%. The company report on December 20, 2020 that Pomerantz Law Firm Announces the Filing of a Class Action against Intercept Pharmaceuticals, Inc. and Certain Officers – ICPT.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Pomerantz LLP announces that a class action lawsuit has been filed against Intercept Pharmaceuticals, Inc. (“Intercept” or the “Company”) (NASDAQ: ICPT) and certain of its officers. The class action, filed in United States District Court for the Eastern District of New York, and docketed under 20-cv-05377, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise, acquired Intercept securities between September 28, 2019 and October 7, 2020, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

If you are a shareholder who purchased Intercept securities during the class period, you have until January 4, 2021, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Intercept Pharmaceuticals Inc. stock is now -77.14% down from its year-to-date (YTD) trading value. ICPT Stock saw the intraday high of $30.78 and lowest of $28.01 per share. The company’s 52-week high price is 125.00, which means current price is +4.85% above from all time high which was touched on 01/02/20.

Compared to the average trading volume of 827.57K shares, ICPT reached a trading volume of 2967948 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Intercept Pharmaceuticals Inc. [ICPT]?

Robert W. Baird have made an estimate for Intercept Pharmaceuticals Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on November 10, 2020. The new note on the price target was released on November 10, 2020, representing the official price target for Intercept Pharmaceuticals Inc. stock. Previously, the target price had yet another raise to $82, while Piper Sandler analysts kept a Overweight rating on ICPT stock.

The Average True Range (ATR) for Intercept Pharmaceuticals Inc. is set at 2.18, with the Price to Sales ratio for ICPT stock in the period of the last 12 months amounting to 3.32.

How has ICPT stock performed recently?

Intercept Pharmaceuticals Inc. [ICPT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.75. With this latest performance, ICPT shares dropped by -24.17% in over the last four-week period, additionally sinking by -64.93% over the last 6 months – not to mention a drop of -76.10% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ICPT stock in for the last two-week period is set at 30.91, with the RSI for the last a single of trading hit 23.84, and the three-weeks RSI is set at 35.14 for Intercept Pharmaceuticals Inc. [ICPT]. The present Moving Average for the last 50 days of trading for this stock 33.32, while it was recorded at 30.58 for the last single week of trading, and 54.06 for the last 200 days.

Intercept Pharmaceuticals Inc. [ICPT]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Intercept Pharmaceuticals Inc. [ICPT] shares currently have an operating margin of -123.98 and a Gross Margin at +94.74. Intercept Pharmaceuticals Inc.’s Net Margin is presently recorded at -136.78.

Return on Total Capital for ICPT is now -63.14, given the latest momentum, and Return on Invested Capital for the company is -70.11. Return on Equity for this stock declined to -975.25, with Return on Assets sitting at -54.54. When it comes to the capital structure of this company, Intercept Pharmaceuticals Inc. [ICPT] has a Total Debt to Total Equity ratio set at 1,062.45. Additionally, ICPT Total Debt to Total Capital is recorded at 91.40, with Total Debt to Total Assets ending up at 72.56. Long-Term Debt to Equity for the company is recorded at 1,049.93, with the Long-Term Debt to Total Capital now at 90.32.

Reflecting on the efficiency of the workforce at the company, Intercept Pharmaceuticals Inc. [ICPT] managed to generate an average of -$591,220 per employee. Receivables Turnover for the company is 7.91 with a Total Asset Turnover recorded at a value of 0.40.Intercept Pharmaceuticals Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.40 and a Current Ratio set at 3.40.

Earnings analysis for Intercept Pharmaceuticals Inc. [ICPT]

With the latest financial reports released by the company, Intercept Pharmaceuticals Inc. posted -2.99/share EPS, while the average EPS was predicted by analysts to be reported at -2.67/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -12.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ICPT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Intercept Pharmaceuticals Inc. go to -8.89%.

Insider trade positions for Intercept Pharmaceuticals Inc. [ICPT]

There are presently around $814 million, or 88.90% of ICPT stock, in the hands of institutional investors. The top three institutional holders of ICPT stocks are: FMR LLC with ownership of 3,727,918, which is approximately -22.678% of the company’s market cap and around 14.20% of the total institutional ownership; VANGUARD GROUP INC, holding 2,739,825 shares of the stock with an approximate value of $77.62 million in ICPT stocks shares; and BLACKROCK INC., currently with $61.75 million in ICPT stock with ownership of nearly -8.612% of the company’s market capitalization.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Positions in Intercept Pharmaceuticals Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 90 institutional holders increased their position in Intercept Pharmaceuticals Inc. [NASDAQ:ICPT] by around 5,991,813 shares. Additionally, 102 investors decreased positions by around 4,267,202 shares, while 39 investors held positions by with 18,473,463 shares. The mentioned changes placed institutional holdings at 28,732,478 shares, according to the latest SEC report filing. ICPT stock had 33 new institutional investments in for a total of 1,122,703 shares, while 48 institutional investors sold positions of 2,009,648 shares during the same period.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on skype
Skype
Share on reddit
Reddit

Leave a Comment

Your email address will not be published. Required fields are marked *

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam